Aquestive Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AQUESTIVE, and when can generic versions of AQUESTIVE drugs launch?
AQUESTIVE has three approved drugs.
There are five US patents protecting AQUESTIVE drugs. There is one tentative approval on AQUESTIVE drugs.
There are one hundred and ninety-three patent family members on AQUESTIVE drugs in twenty-three countries.
Summary for Aquestive
| International Patents: | 193 |
| US Patents: | 5 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Patent Litigation for Aquestive: | See patent lawsuits for Aquestive |
| PTAB Cases with Aquestive as petitioner: | See PTAB cases with Aquestive as petitioner |
Drugs and US Patents for Aquestive
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-005 | Apr 26, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-002 | Apr 26, 2024 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-004 | Apr 26, 2024 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | DISCN | Yes | No | 8,603,514 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-001 | Jul 2, 2010 | DISCN | Yes | No | 8,580,830 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-001 | Apr 26, 2024 | RX | Yes | No | 11,273,131 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-005 | Apr 26, 2024 | RX | Yes | Yes | 11,273,131 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aquestive
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | 8,603,514 | ⤷ Subscribe |
| Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | 8,765,167 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Aquestive Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Malaysia | 181159 | ⤷ Subscribe |
| China | 1764443 | ⤷ Subscribe |
| Israel | 273479 | ⤷ Subscribe |
| Austria | 553746 | ⤷ Subscribe |
| Japan | 2013028635 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 03030883 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2006039264 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
